Zeitlin; Larry

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zeitlin; Larry.The latest application filed is for "monoclonal antibodies and cocktails for treatment of ebola infections".

Company Profile

8.7.14

Zeitlin; Larry - San Diego CA
Zeitlin; Larry - San Deigo CA
Zeitlin; Larry - Poway CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Monoclonal antibodies and cocktails for treatment of Ebola infections Grant 11,407,817 - Bornholdt , et al. August 9, 2	2022-08-09
Monoclonal antibodies and cocktails for treatment of Ebola infections Grant 11,407,816 - Bornholdt , et al. August 9, 2	2022-08-09
Monoclonal antibodies and cocktails for treatment of Ebola infections Grant 11,254,732 - Bornholdt , et al. February 22, 2	2022-02-22
Monoclonal antibodies and cocktails for treatment of Ebola infections Grant 11,242,379 - Bornholdt , et al. February 8, 2	2022-02-08
Monoclonal antibodies and cocktails for treatment of Ebola infections Grant 11,242,378 - Bornholdt , et al. February 8, 2	2022-02-08
Monoclonal antibodies and cocktails for treatment of ebola infections Grant 10,836,810 - Bornholdt , et al. November 17, 2	2020-11-17
Monoclonal Antibodies And Cocktails For Treatment Of Ebola Infections App 20200354438 - Bornholdt; Zachary A. ; et al.	2020-11-12
Monoclonal Antibodies And Cocktails For Treatment Of Ebola Infections App 20200354437 - Bornholdt; Zachary A. ; et al.	2020-11-12
Monoclonal Antibodies And Cocktails For Treatment Of Ebola Infections App 20200299362 - Bornholdt; Zachary A. ; et al.	2020-09-24
Monoclonal Antibodies And Cocktails For Treatment Of Ebola Infections App 20200299361 - Bornholdt; Zachary A. ; et al.	2020-09-24
Monoclonal Antibodies And Cocktails For Treatment Of Ebola Infections App 20200299363 - Bornholdt; Zachary A. ; et al.	2020-09-24
Monoclonal Antibody Cocktails For Treatment Of Ebola Infections App 20190263894 - Hiatt; Andrew ; et al.	2019-08-29
Monoclonal Antibody Cocktails For Treatment Of Ebola Infections App 20190247501 - Hiatt; Andrew ; et al.	2019-08-15
Method of purifying monoclonal antibodies Grant 10,214,747 - Morton , et al. Feb	2019-02-26
Monoclonal Antibodies And Cocktails For Treatment Of Ebola Infections App 20180244758 - Bornholdt; Zachary A. ; et al.	2018-08-30
Method Of Purifying Monoclonal Antibodies App 20160333365 - Morton; Josh ; et al.	2016-11-17
Monoclonal Antibody Cocktails For Treatment Of Ebola Infections App 20160324965 - Hiatt; Andrew ; et al.	2016-11-10
Monoclonal Antibody Cocktails For Treatment Of Ebola Infections App 20160326234 - Hiatt; Andrew ; et al.	2016-11-10
MONOCLONAL ANTIBODIES WITH ALTERED AFFINITIES FOR HUMAN FCyRI, FCyRIIIa, AND C1q PROTEINS App 20130149300 - Hiatt; Andrew ; et al.	2013-06-13

Company Registrations

NCAGE Code	4YSQ7	ZEITLIN, LARRY
NCAGE Code	4Z2F7	ZEITLIN LARRY!DBA MILFORD MOTEL
CAGE Code	4Z2F7	ZEITLIN, LARRY MILFORD MOTEL
CAGE Code	4YSQ7	ZEITLIN, LARRY
DUNS	077473973	ZEITLIN, LARRY

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.